Naltrexone/Bupropion Cardiovascular Outcomes Study
Clinical trial NCT02638129 · TERMINATED
Trial details
- NCT number
- NCT02638129
- Sponsor
- Orexigen Therapeutics, Inc
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2016-06-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.